Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
To assess the angiotensin II blocker effects on platelet (PL) aggregation in patients with arterial hypertension (AH) and metabolic syndrome (MS). In total, 35 patients received losartan for 16 weeks. Dynamics of plasma and PL lipid peroxidation, blood and PL antioxidant protection, and PL aggregati...
Saved in:
Main Authors: | I. N. Medvedev, T. A. Kumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2008-10-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
by: I. N. Medvedev, et al.
Published: (2007-06-01) -
Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-02-01) -
Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01) -
Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01) -
Quantitative morphological characteristics of intravascular platelet activity in patients with diabetes mellitus type 2 with arterial hypertension under losartan treatment
by: Dzyak G.V., et al.
Published: (2012-01-01)